Millennium Management’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-91,576
| Closed | -$119K | – | 5988 |
|
|
2025
Q2 | $119K | Sell |
91,576
-21,669
| -19% | -$26.1K | ﹤0.01% | 5489 |
|
|
2025
Q1 | $157K | Buy |
+113,245
| New | +$248K | ﹤0.01% | 5353 |
|
|
2024
Q2 | – | Sell |
-50,421
| Closed | -$236K | – | 5824 |
|
|
2024
Q1 | $236K | Sell |
50,421
-106,947
| -68% | -$555K | ﹤0.01% | 5279 |
|
|
2023
Q4 | $768K | Sell |
157,368
-385,605
| -71% | -$1.6M | ﹤0.01% | 4350 |
|
|
2023
Q3 | $2.52M | Buy |
542,973
+35,904
| +7% | +$206K | ﹤0.01% | 3346 |
|
|
2023
Q2 | $3.75M | Buy |
507,069
+386,429
| +320% | +$2.58M | ﹤0.01% | 2924 |
|
|
2023
Q1 | $987K | Buy |
120,640
+95,556
| +381% | +$998K | ﹤0.01% | 4110 |
|
|
2022
Q4 | $240K | Sell |
25,084
-215,149
| -90% | -$2.65M | ﹤0.01% | 5224 |
|
|
2022
Q3 | $2.82M | Sell |
240,233
-477,830
| -67% | -$6.29M | ﹤0.01% | 3446 |
|
|
2022
Q2 | $9.23M | Buy |
718,063
+41,261
| +6% | +$428K | 0.01% | 2136 |
|
|
2022
Q1 | $7.44M | Buy |
676,802
+91,944
| +16% | +$1.07M | ﹤0.01% | 2494 |
|
|
2021
Q4 | $8.95M | Buy |
584,858
+230,434
| +65% | +$3.01M | ﹤0.01% | 2257 |
|
|
2021
Q3 | $4.95M | Buy |
354,424
+247,552
| +232% | +$4.14M | ﹤0.01% | 2870 |
|
|
2021
Q2 | $2.07M | Buy |
+106,872
| New | +$2.21M | ﹤0.01% | 3917 |
|
Millennium Management's AKYA Position: Q3 2025 in Review
Millennium Management sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 91,576 shares — an estimated $119K sold.
Millennium Management first reported a position in AKYA in Q2 2021 and held it in 14 quarters. The position peaked at $9.23M in Q2 2022. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.
- Millennium Management reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
- Millennium Management sold 91,576 Akoya BioSciences shares in Q3 2025, an estimated $119K.
- Millennium Management first reported a position in Akoya BioSciences in Q2 2021 and held it in 14 quarters.
- Millennium Management's Akoya BioSciences position peaked at $9.23M in Q2 2022.
- 0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.
Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.